Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105138 · ClinicalTrials.gov registry record · NA
Cannabidiol Effects on Blood Alcohol Level and Intoxication
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT06105138 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 37 participants.
The verdict
NCT06105138, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The main objectives of this study were to test if 2 different doses of Cannabidiol (compared to placebo) alter 1) breath alcohol concentration, 2) craving and subjective responses to alcohol or 3) cognitive performance following a standard dose of alcohol.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 200mg Cannabidiol oral solution
- DIETARY_SUPPLEMENT 30mg Cannabidiol oral solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2022-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06105138
The ClinicalTrials.gov registry entry for NCT06105138 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06105138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06105138 about?
NCT06105138 is a clinical study titled "Cannabidiol Effects on Blood Alcohol Level and Intoxication". The main objectives of this study were to test if 2 different doses of Cannabidiol (compared to placebo) alter 1) breath alcohol concentration, 2) craving and subjective responses to alcohol or 3) cognitive performance following a standard dose of alcohol.
What is the current status of trial NCT06105138?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-03-09. Estimated completion is 2022-03-03.
What interventions are being tested in trial NCT06105138?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 200mg Cannabidiol oral solution (DIETARY_SUPPLEMENT), 30mg Cannabidiol oral solution (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06105138?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.